Wellpoint’s Massachusetts plans, offered through the Group Insurance Commission, cover Wegovy for weight loss through June 30, 2026. Starting July 1, 2026, that coverage ends for members using the drug solely for weight management. Coverage continues in two situations: if you’re taking a GLP-1 for diabetes, or if you have a BMI of 27 or higher along with an FDA-approved comorbid condition.1Massachusetts GIC. April Update on Vida Health Program and GLP-1 Coverage
Who Actually Runs the Drug Benefit
Wellpoint offers several GIC plans, including Total Choice, PLUS, and Community Choice for non-Medicare members, and a Medicare Extension plan for retirees.2Wellpoint. Health Plans Whichever plan you’re on, the prescription drug benefit for non-Medicare GIC plans is administered by CVS Caremark, not Wellpoint directly. Formulary decisions, prior authorization requirements, and coverage rules for Wegovy all run through CVS Caremark, and Wellpoint states it isn’t responsible for CVS Caremark’s policies.3Wellpoint. Pharmacy Benefits
Wegovy does appear on the CVS Caremark formulary used by GIC plans, listed under the “Antiobesity” category alongside Saxenda, Qsymia, and orlistat. Diabetes-focused GLP-1s like Ozempic, Mounjaro, and Rybelsus sit under a separate “Antidiabetics” category. Being on the formulary isn’t the same as being covered. The document itself warns that “your specific prescription benefit plan design may not cover certain medications, products or categories, regardless of their appearance in this document.”4Wellpoint. Formulary for Non-Specialty Drugs Zepbound, another weight loss drug, was removed from the GIC formulary effective July 1, 2025.3Wellpoint. Pharmacy Benefits
What Changes on July 1, 2026
On February 26, 2026, the GIC board voted 10–7 to eliminate GLP-1 coverage when prescribed solely for weight loss.5WGBH. Weight Loss Drugs Will No Longer Be Covered by Mass. State Workers’ Health Insurance Roughly 22,000 members were taking these drugs for weight loss at the time of the vote, at a total cost of $46 million.6WBUR. GLP-1 Weight Loss Drug Coverage State Workers
Starting July 1, 2026, GIC plans no longer cover GLP-1 medications for treatment of obesity in members who don’t have an FDA-approved comorbidity. After that date, prescriptions are handled through your regular community healthcare provider rather than a specialty program, and every GLP-1 prescription requires prior authorization through CVS Caremark.1Massachusetts GIC. April Update on Vida Health Program and GLP-1 Coverage
Who Still Qualifies After July 1
Coverage continues for two groups. The first is members using a GLP-1 to treat diabetes. The second is members with a BMI of 27 or higher who also have an FDA-approved comorbid condition.1Massachusetts GIC. April Update on Vida Health Program and GLP-1 Coverage
If you’re on Medicare, note that Medicare Part D generally doesn’t cover drugs prescribed for weight loss, though it can cover Wegovy specifically for cardiovascular risk reduction under the FDA’s approved indication.7Massachusetts Health Policy Commission. Blockbuster GLP-1 Weight Loss Drugs Massachusetts
Prior Authorization Criteria for Wegovy
For members who still qualify, CVS Caremark’s prior authorization criteria are specific. For weight management in adults, you need a BMI of 30 or higher, or a BMI of 27 or higher paired with at least one weight-related comorbid condition such as hypertension, type 2 diabetes, or dyslipidemia. You must also have participated in a comprehensive weight management program involving behavioral modification, diet, and physical activity for at least six months before starting the medication.8CVS Caremark. Wegovy Prior Authorization Criteria
To keep therapy going, you need to have completed at least three months at a stable maintenance dose and demonstrated a weight loss of at least 5% from baseline, or maintained an earlier 5% weight loss. Wegovy can also be approved for cardiovascular risk reduction in adults aged 45 and older who have established cardiovascular disease and a BMI above 27, provided the patient doesn’t have type 2 diabetes. A separate approval pathway exists for noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis.8CVS Caremark. Wegovy Prior Authorization Criteria
Appealing a Denied Wegovy Claim
If CVS Caremark denies your Wegovy claim, you can appeal. Wellpoint’s member handbook describes a formal appeals program for prescription drug decisions, with an internal review process and the option for external review if the internal appeal doesn’t succeed. You have to complete the internal appeal before filing a lawsuit. CVS Caremark’s GIC customer service line for prescription drug questions is 877-876-7214.9Wellpoint. Wellpoint PLUS Member Handbook
What Wegovy Costs Without Coverage
Patients losing GLP-1 coverage face out-of-pocket costs of up to $450 per month.10WBUR. Mass. Cutting GLP-1 Coverage Medicaid Wegovy Zepbound If you no longer meet the criteria after July 1, that’s the price range to plan around, and it’s worth talking with your prescriber about whether a comorbid condition on your record could qualify you under the exception before assuming you’ll pay cash.